Biblio

Author Title [ Type

] Year

Filters: Author is Cao, Xing-Yu [Clear All Filters]

Journal Article

Cao X-Y, Chen J-Q, Wang H, Ma W, Liu W-W, Zhang F-F, Xue S, Dong L, Liu T, Zhao X-Z, et al. Addition of venetoclax to myeloablative conditioning regimens for allogeneic hematopoietic stem cell transplantation in high-risk AML. Ann Med. 2023;55(1):388-400.

Cao X-Y, Zhang J-P, Zhao Y-L, Xiong M, Zhou J-R, Lu Y, Sun R-J, Wei Z-J, Liu D-Y, Zhang X, et al. Analysis benefits of a second Allo-HSCT after CAR-T cell therapy in patients with relapsed/refractory B-cell acute lymphoblastic leukemia who relapsed after transplant. Front Immunol. 2023;14:1191382.

Xue S, Sun H-P, Huang X-B, Chen X, Wang T, Ma W, Tian Y, Pan Z-L, Li L-H, Zhang L, et al. Characteristics and literature review of ETV6::ABL1 fusion gene-positive acute myeloid leukemia. Int J Hematol. 2024.

Lu Y, Xiong M, Sun R-J, Zhang J-P, Zhao Y-L, Wei Z-J, Cao X-Y, Zhou J-R, Liu D-Y, Lu D-P. Comparisons of unmanipulated haploidentical donor, unrelated cord blood donor and matched unrelated donor hematopoietic stem cell transplantation in pediatric acquired severe aplastic anemia: a single center study. Leuk Lymphoma. 2022:1-10.

Cao X-Y, Zhang J-P, Lu Y, Zhao Y-L, Liu D-Y, Xiong M, Sun R-J, Wei Z-J, Zhou J-R, Zhang X, et al. A safety and efficacy study of allogeneic haematopoietic stem cell transplantation for refractory and relapsed T-cell acute lymphoblastic leukaemia/lymphoblastic lymphoma patients who achieved complete remission after autologous CD7 chimeric antigen recep. Br J Haematol. 2024.